pacific gas and electric company® james m. welsch · j prehs f2 to view drugs.client profile...

8
Pacific Gas and Electric Company® June 15, 2017 PG&E Letter DCL-17-059 James M. Welsch Vice President, Nuclear Generation Diablo Canyon Power Plant Mail Code 104/6 P. 0. Box 56 Avila Beach, CA 93424 805.545.3242 Internal: 691.3242 Fax: 805.545.4884 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555-0001 10 CFR 26.719(c) Docket No. 50-275, OL-DPR-80 Docket No. 50-323, OL-DPR-82 Diablo Canyon Power Plant Units 1 and 2 10 CFR 26.719(c) Notification- Testing Error for Two Specimens Dear Commissioners and Staff: In accordance with 10 CFR 26.719(c), "Drug and alcohol testing errors," Pacific Gas & Electric Company (PG&E) is submitting the enclosed report of an investigation regarding a testing error associated with the Diablo Canyon Power Plant Fitness for Duty (FFD) Program. On April11, 2017, two specimen test reports were provided by Laboratory Corporation of America (LabCorp) testing facility to the Medical Review Officer Department Staff (MR0-0). LabCorp is a Health and Human Services certified laboratory. Upon the review of test results by the MR0-0, it was identified that initial specimen validity testing of the two samples (as required by 10 CFR 26.161 (b)) was not completed. LabCorp was notified of this issue. Upon further review of the test results, it was noted the cutoff levels for two of the drugs and drug metabolites (marijuana and opiates) were not at the levels required by 10 CFR 26.163. The enclosure contains the documented outcome of LabCorp's investigation and corrective action. · PG&E makes no new or revised regulatory commitments (as defined by NEI 99-04) in this letter. - If you have any questions regarding the enclosed information or other FFD program activities, please contact Ms. Charlene Miller, Access Authorization/FFD Manager, at 805-545-2672. A member of the STARS Alliance Callaway Diablo Canyon • Palo Verde Wolf Creek

Upload: others

Post on 28-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

Pacific Gas and Electric Company®

June 15, 2017

PG&E Letter DCL-17-059

James M. Welsch Vice President, Nuclear Generation

Diablo Canyon Power Plant Mail Code 104/6 P. 0. Box 56 Avila Beach, CA 93424

805.545.3242 Internal: 691.3242 Fax: 805.545.4884

U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555-0001

10 CFR 26.719(c)

Docket No. 50-275, OL-DPR-80 Docket No. 50-323, OL-DPR-82 Diablo Canyon Power Plant Units 1 and 2

10 CFR 26.719(c) Notification- Testing Error for Two Specimens

Dear Commissioners and Staff:

In accordance with 10 CFR 26.719(c), "Drug and alcohol testing errors," Pacific Gas & Electric Company (PG&E) is submitting the enclosed report of an investigation regarding a testing error associated with the Diablo Canyon Power Plant Fitness for Duty (FFD) Program.

On April11, 2017, two specimen test reports were provided by Laboratory Corporation of America (LabCorp) testing facility to the Medical Review Officer Department Staff (MR0-0). LabCorp is a Health and Human Services certified laboratory.

Upon the review of test results by the MR0-0, it was identified that initial specimen validity testing of the two samples (as required by 10 CFR 26.161 (b)) was not completed. LabCorp was notified of this issue. Upon further review of the test results, it was noted the cutoff levels for two of the drugs and drug metabolites (marijuana and opiates) were not at the levels required by 10 CFR 26.163.

The enclosure contains the documented outcome of LabCorp's investigation and corrective action. ·

PG&E makes no new or revised regulatory commitments (as defined by NEI 99-04) in this letter. -

If you have any questions regarding the enclosed information or other FFD program activities, please contact Ms. Charlene Miller, Access Authorization/FFD Manager, at 805-545-2672.

A member of the STARS Alliance

Callaway • Diablo Canyon • Palo Verde • Wolf Creek

Page 2: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

Document Control Desk June 15, 2017 Page2

Sincerely,

d:;-;.t=J__ Vice President, Nuclear Generation

armb/4743/50915748 Enclosure

PG&E Letter DCL-17-059

cc/enc: Kriss M. Kennedy, NRC Region IV Administrator Christopher W.· Newport, NRC Senior Resident Inspector Balwant K. Singal, NRC Project Manager

A member of the STARS Alliance

Callaway • Diablo Canyon • Palo Verde • Wolf Creek

Page 3: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

Enclosure PG&E Letter DCL-17 -059

LabCorp Occupational Testing Services Wrong Profile Used for 0178511705 and 0178456414

Page 4: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

May 22, 2017

Ms. Charlene Miller Access/FFD Manager Pacific Gas and Electric Company Diablo Canyon Power Plant P.O. Box 56 Avila Beach, California 93423

RE: Wrong Profile Used for 0178511705 and 0178456414

Dear Ms. Miller:

LaboratOr)' Corpora tion ol America® Holdings PO Bux "12G52 1904 Alexander Drive Research Triangle Park, Norrh Carolina 27709

Telephone: 800-833-3984 91 9-572-6900

Specimen ID Numbers 0178511705 and 0178456414 were received by Laboratory Corporation of America Holdings in Research Triangle Park, North Carolina on April 11r 2017. The specimens were tested and reported on April11, 2017. However, on April 12, 2017 and again on April27, 2017, LabCorp was notified by PG&E that specimen validity testing had not been reported on these two samples. A review of data at the laboratory confirmed that the specimen validity testing had not been performed and two of the drugs tested were at the wrong initial test cutoffs.

Our investigation determined that specimen ID Numbers 017851170? and 0178456414 should have been tested using Profile 16 under Order Number 15 for PG&E account 3001. Instead, the data entry operator entered Profile 6 which did not include the specimen validity testing and did not have the correct initial test cutoffs for THC and Opiates. PG&E did notify the key account specialist assigned to your account on April 12r 2017 that the reports for these two specimens were missing some of the required results. Miscommunication between the key account specialist and the customer care editors caused the specimens not to be set up for the additional testing. By the time laboratoty management was notified on· April 27r 2017, the laboratory was unable to perform the correct testing on these two specimens because they had been discarded in accordance with the Standard Operating Procedure.

Retraining has been conducted with the 9ata entry operator who ordered the wrong profile on these specimens. In addition, Profile 6 has been made inactive and Profile 16 is currently the only active profile for PG&E Account 3001. Client Profile Maintenance screens are attached that confirm that profile 16 is active ("A") and contains the required assays at the require cutoffs; screens attached also confirm that Profile 6 is inactive ("I") and did not contain the required assays at the required cutoffs.

Retraining is also being conducted with the key account specialist and customer care editor to perform all requested edits in a timely manner to ensure testing can be completed.

We apologize for any inconvenience this incident may cause you . : If we can be of further assistance to you, please do not hesitate to call Phyllis Chandler at 919-572-7512 or Michael Bachmann at 919-224-5293.

S2Jrely,

Y'f/ f<: (}~---U---Phyllis K. Chandler Responsible Person

t1Miitl Michael Bachmann i Responsible Person

Page 5: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

J

PreHs F2 to view drugs .

Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609

Action R (Add, Retrieve, Change)

Account 3001.- *k Contract Books ** Ot~der 16 Cont f.\CCt

Pro·fne (16'·~\ ........ ,.,,..!

oocc oocc

Contr'aot 702 PACIFIC GAS & ELECTRIC P.O. 350 '1 097098

Account Class DI Oelivet'ables C~~-..q 00 Y 5

(Status A._\ ~~.,.,..__.,1~--./

Page 6: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

.j

·:; • • ·.·.-• • -•..• ,-• • , ., ,•.·.;-. ;-;;-,•. ; ,•-·· ·"·· · · · · .... . ~o • •• • ••• • • ••••• _ . . . -.-...

Press F~ t o display another Profile; F5 and 'F6 to scroll; FB t o exit . Client Profile for Drug Analysis

t\ocount 00300·1 PACtFIC GAS & ELECTlUC Order OOOOi5 Profile @16) Turnaround ? 3 Contr·aot Books: Cont oocc 7\CC~ oocc

Ot·der 8 s 8 s s s 8 s s s 0 0

0 0 s s

DI,Ug Amphetamines Gocalne Harij uana Hotab . Opiates PCP Gr·eatJnine Isomer 6 -Acetyl Mol'phine pH Nitr:J.te

- -Screen-­Cutoff

1000 . 00 300.00

50.00 . 2000.00

25.00

200.00

Test Number 789609 CR BUNDLED

--Confirm-~

Cutof-F 600,00 : 150 . 00 , 15.00

2000, 00 I

25.00

2.00.00

--Confirm-· Test Nbr

Page 7: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

Pn:s~l F2 to v:Lev·I clruus ..

Cli.ent PI'o'fHf.l Maintenance for Drug Analysis MAPS TO TESTlj 011615

Action R (Add, RetPieve, Change)

Account Oi~det'

Pr·o'file

Contt~aot

P.O.

Account Class . Deliverables Code

Status

3001 15

(:~),

** Contract Books ** Cont Acot oocc oocc

702 PAGIFIC GAS & ELECTRIC 3500487'1 05

DI

6A oo 00 Y

I ) ~ ... -

Page 8: Pacific Gas and Electric Company® James M. Welsch · J PreHs F2 to view drugs.Client Profile Maintenance for Drug Analysis MAPS TO TEST# 789609 Action R (Add, Retrieve, Change) Account

j :!

i ~ . .;

~~

~1

1 j

·.~

.::1

:J

J

.~ !~J .TI i]

Pi''GSS F·l to displD.y 3tlotll<H' Pro·fDe; F5 and F6 to so r-oll; FB l:o 8><it, Client Pr·o"l'ilH ·r'ol" Drug Ana1ys:Ls

Account 003001 PACIFIC GAS & ELECTRIC Order 0 o o o 15 PI~ of ile (6-006""') Tu t'nat'OLinCI 2 3 Contract Bool<s: Cont oocc AcCt oocc

Ot,der s 8 8 s s s s s s s

DI'UG Amplletam.i.nes Cocaine 11ar'ij u ana Mst ab. Op.i.ates PCP Isolllet' 6-Acetyl Morphina

--screen-­cutoff

1000.00 300.00 100.00 300.00

25.00

Test Number 011615 CFl BUNDLED

-·Confirm-­cutoff

500.00 i50.00

; 5' 00 300.00 25.00

--Confirm--· Test Nbr

~ il f;

~ ~ ~. ~ ~ ~:

~ n

l i ~ ~

I ' ~ •t